-
$3.1 Million Grant Supports Exploration of Immune Response to Cancer Mutations
Rutgers Cancer Institute of New Jersey investigators collaborate on translational research. Learn more
-
Cancer Immunology and Metabolism Center of Excellence
A generous donation of $25 million will support cancer research to help scientists better understand the human immune response to cancer and ultimately develop the foundation for new treatments or make existing therapies more effective. Learn more
-
Research May Better Inform Burkitt Lymphoma Treatment
Dr. Andrew Evens and international collaborators show validation of Novel Prognostic Index may better inform Burkitt lymphoma treatment. Read more
-
$1.33 Million Award Supports Research to Better Inform HER2 Breast Cancer Treatment
A Rutgers Cancer Institute collaboration with George Mason University received the U.S. Army’s Breast Cancer Research Program Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized treatments. Read more
-
February is Cancer Prevention Month
Visit our Cancer Prevention Resource Center for more information about cancer screening. Learn more
-
Negligible Detection of SARS-CoV2 RNA found in Hematology/ Oncology Inpatient and Outpatient Settings
Rutgers Cancer Institute researchers evaluated the frequency of SARS-CoV-2 RNA on various environmental surfaces and found extremely low detection of SARS-CoV-2 across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor. Learn more
-
50th Anniversary of the National Cancer Act
Rutgers Cancer Institute in partnership with the NCI celebrate the 50th anniversary of the National Cancer Act. Learn more
-
Patient Care
From doctor to nurse to social worker and others, our comprehensive team guides both patient and family through their cancer journey. Learn more
Patient Education Library
Patient Support Services
Your cancer care is too important to wait
Find out how we are keeping our patients and team members safe during this time
-
Clinical Trials
As one of the National Cancer Institute’s designated cancer centers, the Rutgers Cancer Institute of New Jersey provides access to the latest medicines through clinical trials.
Learn more
-
Research
Cancer research is one of the pillars of the Cancer Institute of New Jersey. Our physician-scientists engage in innovative techniques to unlock the mysteries of cancer, helping to make unique advances in the field.
Learn more about our Research
Visit our newsroom
Shedding Light on the Forgotten Cancer
Learn more
Exploring Genetic and Random Influences upon Tumor Formation and Tumor Types
Learn more
Negligible Detection of SARS-CoV2 RNA found in Environmental Surface Testing of Hematology/ Oncology Inpatient and Outpatient Settings
Learn more
Rutgers University Cancer Prevention Researcher and Leader Named President-Elect of American Society of Preventative Oncology
Learn more
Mason Scientists and Rutgers Cancer Institute of New Jersey Collaboration Receives U.S. Army’s Breakthrough Award to Better Inform HER2 Breast Cancer Treatment
Learn more
Exploring Impact of Surgery Delays for Clinical Renal Cell Carcinoma Patients during the COVID-19 Pandemic
Learn more
